NCT06898164

Brief Summary

This retrospective study aimed to investigate the subjective and objective visual outcomes following Small Incision Lenticule Extraction (SMILE) surgery in high myopic patients with varying axial lengths (AL).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 13, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

3.2 years

First QC Date

March 13, 2025

Last Update Submit

March 20, 2025

Conditions

Keywords

Axial lengthHigh myopiaSMILEHigher-order aberrationvisual quality

Outcome Measures

Primary Outcomes (1)

  • Subjective visual quality

    The quality of vision (QOV) questionnaire consists of (i) symptom frequency, (ii) severity, and (iii) bothersomeness for (a) glare, (b) halo, (c) starbursts, (d) hazy vision, (e) blurred vision, (f) distortion, (g) multiple images, (h) visual fluctuations, (i) difficulty focusing, and (j) difficulty judging distance or depth perception. Respondents use a scale of 0 to 3, where zero (0) denotes "none," one (1) "a little," two (2) "quite a bit," and three (3) "very much." Furthermore, on a scale from 0 to 10, patients were asked to provide Likert ratings for "daytime" and "nighttime" quality of vision (0 denoting the poorest vision, while 10 indicating the best vision)

    12 months

Secondary Outcomes (1)

  • Refractive results

    12 months

Other Outcomes (1)

  • Ocular high-order aberrations

    12 months

Study Arms (3)

AL < 26 mm

high myopic patients with axial lengths \< 26 mm

Other: This study does not involve any interventions

26 mm ≤ AL < 27 mm

high myopic patients with 26 mm ≤ axial lengths \< 27 mm

Other: This study does not involve any interventions

AL ≥ 27 mm

high myopic patients with axial lengths ≥ 27 mm

Other: This study does not involve any interventions

Interventions

This study does not involve any interventions

26 mm ≤ AL < 27 mmAL < 26 mmAL ≥ 27 mm

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

A total of 113 high myopic patients (202 eyes) of Shanghai's Tenth People's Hospital were enroled in this prospective, non-randomized study conducted from July 2021 to September 2023.

You may qualify if:

  • manifest refraction spherical equivalent refraction exceeding -6.00D;
  • stable myopia for a duration of at least 2 years;
  • corrected distance visual acuity of at least 20/25;
  • annual myopic spherical equivalent increment less than - 0.50 D.

You may not qualify if:

  • a history of moderate to severe dry eye as well as any ocular or systemic disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 13, 2025

First Posted

March 27, 2025

Study Start

July 1, 2021

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

March 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations